Artificial Intelligence-Based Risk Stratification in Obesity Care: From Diagnosis to Personalised Treatment Pathways

Obesity remains a persistent health challenge, yet specialist resources often fail to meet rising patient demands. Current clinical workflows frequently struggle to provide timely interventions for individuals at high risk of complications. No prior work had resolved how automated computational tools might bridge this service gap effectively. It was already known that traditional weight-based metrics often overlook the complex biological diversity of patients. This uncertainty drove the need to evaluate emerging digital solutions for better patient stratification. Prior research has shown that data-driven models could potentially enhance diagnostic accuracy in various chronic conditions. That gap motivated a comprehensive look at how machine learning might transform standard obesity management strategies. The authors address this by synthesizing current evidence on digital tools within the obesity care continuum.

The primary aim of this review is to synthesize contemporary digital applications across the obesity care continuum. The authors seek to evaluate the translational readiness of these emerging computational technologies. Obesity is recognized as a chronic, relapsing condition that requires scalable support solutions. A significant gap exists between the clinical need for specialist care and current service availability. This uncertainty drove the researchers to examine how machine learning might enable earlier risk detection. The study also explores how automated tools can provide more precise phenotyping for individual patients. Furthermore, the review investigates the potential for scalable behavioural support through digital platforms. The team provides a structured analysis to guide future clinical implementation and regulatory alignment.

The Review Approach involved a systematic search of PubMed, MEDLINE, and Google Scholar databases. Investigators focused on literature published between January 2024 and January 2026 to ensure topical relevance. Citation chaining served as a secondary strategy to capture pertinent studies missed by initial database queries. The authors categorized the synthesized evidence into four distinct thematic domains. These domains included risk prediction, environmental determinants, multimodal phenotyping, and automated coaching platforms. Reviewers evaluated the translational readiness of each identified digital application. This methodology prioritized studies that demonstrated clear clinical utility within existing treatment frameworks. The team maintained a focus on aligning findings with established regulatory standards for medical software.

Key Findings From the Literature indicate that electronic health record models provide useful discrimination for early patient identification. Multimodal strategies successfully improve stratification accuracy by looking past traditional body mass index metrics. AI-enabled behavioural coaching platforms show emerging evidence of clinically significant weight reduction. These automated systems demonstrate non-inferiority when measured against standard human-led coaching interventions. However, the authors note that long-term effectiveness data remain insufficiently established for widespread clinical adoption. Generalisability of these digital tools across different patient populations also requires further investigation. Equity in algorithmic performance remains a significant concern that current studies have not fully resolved. The findings suggest that digital health integration is currently in a transitional phase of development.

The authors propose that machine learning will likely serve as a primary driver for tailoring obesity treatment plans. Synthesis and Implications suggest that successful integration depends on rigorous external validation of all predictive models. Researchers emphasize that bias auditing is required to ensure equitable outcomes for diverse patient populations. The review highlights that transparent reporting standards must accompany the deployment of these digital health technologies. Human oversight remains a necessary component to maintain safety within automated clinical decision-making processes. Post-deployment surveillance should align with existing medical guidelines and regulatory expectations to protect patient welfare. The evidence indicates that while these tools show promise, long-term effectiveness data are still lacking. Future efforts should focus on establishing the generalizability of these platforms across different healthcare settings.